Praxis Precision Medicines, Inc. (PRAX) is listed on NASDAQ in Pharmaceutical Stocks. It is $345.04, -6.20%, with a $9.6B market cap. RSI is 48.5, neutral. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 48.5 Neutral
Market Cap $9.6B
Volume 287.3K
Fundamentals — 10-Q Q2 2026
Revenue --
Net Income $-176.3M
EPS $-6.08
P/E Ratio -56.8x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Desimone Jill | Director | Sell | 11,600 | $311.32 | $3.6M | 2026 Jun 24 |
| Nemiroff Alex | General Counsel and Secretary | Sell | 25,130 | $193.08 | $4.9M | 2025 Nov 20 |
| Mastrocola Lauren | Principal Accounting Officer | Sell | 13,600 | $192.08 | $2.6M | 2025 Nov 20 |
| Adage Capital Management, L.P. | 10% Owner | Sell | 313,910 | $105.76 | $33.2M | 2025 Oct 16 |
| Mastrocola Lauren | Principal Accounting Officer | Sell | 5,188 | $81.78 | $424,302 | 2024 Nov 14 |
| Nemiroff Alex | General Counsel and Secretary | Sell | 8,239 | $80.20 | $660,794 | 2024 Nov 14 |
| DeSimone Jill | Director | Buy | 14,500 | $1.75 | $25,375 | 2023 Oct 5 |
| Souza Marcio | Chief Executive Officer | Buy | 10,000 | $1.06 | $10,600 | 2023 Jun 27 |
| Mitchell Dean J | Director | Buy | 50,000 | $0.84 | $42,000 | 2023 Mar 24 |
| Kelly Timothy Edwin | Chief Financial Officer | Buy | 8,000 | $0.87 | $6,960 | 2023 Mar 24 |
| Souza Marcio | Chief Executive Officer | Buy | 70,002 | $0.86 | $60,202 | 2023 Mar 23 |
| Mastrocola Lauren | Principal Accounting Officer | Buy | 3,000 | $1.93 | $5,790 | 2022 Jun 16 |
| Nemiroff Alex | General Counsel and Secretary | Buy | 7,500 | $1.63 | $12,225 | 2022 Jun 13 |
| Kelly Timothy Edwin | Chief Financial Officer | Buy | 10,000 | $1.77 | $17,700 | 2022 Jun 9 |
| Mitchell Dean J | Director | Buy | 25,000 | $1.81 | $45,250 | 2022 Jun 8 |
| Souza Marcio | Chief Executive Officer | Buy | 27,000 | $1.85 | $49,950 | 2022 Jun 8 |
| Blackstone Holdings II L.P. | 10% Owner | Sell | 400,000 | $17.50 | $7.0M | 2021 Oct 6 |
| Schwarzman Stephen A | 10% Owner | Sell | 46,546 | $19.14 | $890,904 | 2021 Oct 5 |
| Kelly Timothy Edwin | Chief Financial Officer | Buy | 3,905 | $19.48 | $76,069 | 2021 Aug 31 |
| Blackstone Holdings I/II GP L.L.C. | 10% Owner | Sell | 352,396 | $19.00 | $6.7M | 2021 Aug 23 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $84.85 | 71.8 | $9.0B |
| | $366.76 | 62.3 | $542.1B |
| | $34.17 | 49.9 | $2.5B |
| | $64.65 | 51.0 | $12.5B |
Take PRAX further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put PRAX in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Praxis Precision Medicines, Inc. next reports.
Set alerts on PRAX
Get notified when Praxis Precision Medicines, Inc. hits your price targets or technical conditions are met.
Get Started Free